Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Khalid Nabilsi Insider Profile
4 Followers
Khalid Nabilsi, Chief Financial Officer at Hikma Pharmaceuticals, holds 429.69K shares in Hikma Pharmaceuticals (Ticker: GB:HIK).
Khalid Nabilsi Hikma Pharmaceuticals (HIK)Chief Financial Officer
Hikma Pharmaceuticals (HIK)
Chief Financial Officer
Ranked #14,846 out of 97,944 Corporate Insiders
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+17.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Financial Officer
Roles that Khalid Nabilsi holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Apr 28, 2017 - Apr 28, 2018
Return:+30.20%
The most profitable trade made by Khalid Nabilsi
Khalid Nabilsi's Trading History
List of latest transactions for each holding click on a transaction to see Khalid Nabilsi's performance on stock
You May Also Like
Khalid Nabilsi insider profile FAQ
What is the percentage of profitable transactions made by Khalid Nabilsi?
The percentage of profitable transactions made by Khalid Nabilsi is 83%.
What is the average return per transaction made by Khalid Nabilsi?
The average return per transaction made by Khalid Nabilsi is 17.20%.
What stocks does Khalid Nabilsi hold?
Khalid Nabilsi holds: GB:HIK stocks.
What was Khalid Nabilsi’s latest transaction?
Khalid Nabilsi latest transaction was an Uninformative Buy of ―.
What was Khalid Nabilsi's most profitable transaction?
Khalid Nabilsi’s most profitable transaction was an Informative Sell of GB:HIK stock on April 28, 2017. The return on the trade was 30.20%.
What is Khalid Nabilsi's role in Hikma Pharmaceuticals?
Khalid Nabilsi's role in Hikma Pharmaceuticals is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.